The company
Fortrea Holdings Inc.
FTRE · Nasdaq
FTRE stood above a rising 150-day average in 40 of the last 52 weekly readings, including each of the last 25 weeks. It is 41.2% above that average now. Diagnostics & Labs: 48% of its 44 stocks in an uptrend (−2 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 25 in a row
- Industry in uptrend
- 48% -2 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $9.4M
- Officials’ trades on record
- 1
- Institutions holding
- 314 (+5)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 40 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
1 disclosed lines: House 1, Senate 0, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| J. French Hill House: U.S. House ClerkAR02 | soldspouse | $1k–$15k | 23 Jun 2025filed 24 Jul 2025 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Mark A. MoraisChief Operating Officer | sold | 3,149at $16.85 | 9 Sep 2026filed 10 Sep 2026 |
| Carrie Elizabeth RussellInterim CAO | sold | 246at $16.85 | 9 Sep 2026filed 10 Sep 2026 |
| Mark A. MoraisChief Operating Officer | sold | 4,892at $18.19 | 19 Aug 2026filed 19 Aug 2026 |
| Anshul ThakralChief Executive Officer | sold | 55,882at $18.17 | 6 Aug 2026filed 7 Aug 2026 |
| Anshul ThakralChief Executive Officer | sold | 55,975at $18.06 | 6 Aug 2026filed 7 Aug 2026 |
| Anshul ThakralChief Executive Officer | sold | 49,452at $19.03 | 5 Aug 2026filed 6 Aug 2026 |
| Anshul ThakralChief Executive Officer | sold | 50,417at $19.28 | 5 Aug 2026filed 6 Aug 2026 |
| Machelle SandersDirector | sold | 9,700at $18.01 | 3 Aug 2026filed 5 Aug 2026 |
| Mark A. MoraisChief Operating Officer | sold | 4,674at $16.82 | 10 Jun 2026filed 12 Jun 2026 |
| Jill G. McConnellChief Financial Officer | sold | 4,866at $15.49 | 2 Jun 2026filed 3 Jun 2026 |
| Mark A. MoraisChief Operating Officer | sold | 4,866at $15.49 | 2 Jun 2026filed 3 Jun 2026 |
| Robert ParksChief Accounting Officer | sold | 2,000at $13.44 | 18 May 2026filed 20 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 15,799,104$274.9M | +646,709+4.3% |
| GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026 | 8,414,011$146.4M | +315,494+3.9% |
| Sessa Capital IM, L.P.unchanged · filed 14 Aug 2026 | 4,593,550$79.9M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 4,181,552$72.8M | +142,990+3.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,816,627$66.4M | +119,878+3.2% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 3,784,173$65.8M | -325,227−7.9% |
| FMR LLCadded · filed 13 Aug 2026 | 3,646,931$63.5M | +2,402,794+193.1% |
| Corvex Management LPreduced · filed 14 Aug 2026 | 2,988,551$52.0M | -1,655,642−35.6% |
| AQR CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 2026 | 2,980,474$51.9M | -317,947−9.6% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 2,546,771$44.3M | +180,294+7.6% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.